Corpus ID: 24429125

From conventional pathologic diagnosis to the molecular classification of breast carcinoma: are we ready for the change?

@article{Raica2009FromCP,
  title={From conventional pathologic diagnosis to the molecular classification of breast carcinoma: are we ready for the change?},
  author={Marius Raica and Ioan Jung and Anca Maria C{\^i}mpean and Cristian Suciu and Anca Maria Mureşan},
  journal={Romanian journal of morphology and embryology = Revue roumaine de morphologie et embryologie},
  year={2009},
  volume={50 1},
  pages={
          5-13
        }
}
  • Marius Raica, Ioan Jung, +2 authors Anca Maria Mureşan
  • Published in
    Romanian journal of…
    2009
  • Medicine
  • Breast cancer is the most frequent malignant tumor in women and the diagnosis, prognosis and therapeutic strategy are based on the pathologic report. In last years, it was shown that conventional pathologic diagnosis brings few data about prognosis and tells nothing about the response of the tumor to specific therapy. In an effort to improve the molecular characterization of breast cancer, gene profile analysis was performed in a large number of cases. Based on this analysis, there were… CONTINUE READING

    Create an AI-powered research feed to stay up to date with new papers like this posted to ArXiv

    Citations

    Publications citing this paper.
    SHOWING 1-10 OF 19 CITATIONS

    Molecular Subtypes of Breast Carcinoma in South Indian Women and their Correlation with Histomorphological and Clinical Features

    • Dr. Jessy, Kenneth José, Dr. Priya Mariam Kuruvilla, Dr. Jophy Varghese
    • 2019
    VIEW 5 EXCERPTS
    CITES BACKGROUND
    HIGHLY INFLUENCED

    Correlation between p53 and epidermal growth factor receptor expression in breast cancer classification.

    VIEW 1 EXCERPT
    CITES BACKGROUND

    New Developments in Breast Cancer Prognosis: Molecular Predictors of Treatment Response and Survival

    VIEW 1 EXCERPT
    CITES BACKGROUND

    References

    Publications referenced by this paper.
    SHOWING 1-10 OF 59 REFERENCES

    Basal-like breast cancer, Update in Pathology, 3 Intercontinental Congress of Pathology

    • J S.REIS-FILHO
    • 2008
    VIEW 1 EXCERPT

    Clinical importance of HER 2 immunohistologic heterogeneous expression in core - needle biopsies vs resection specimens for equivocal ( immunohistochemical score 2 + ) cases

    • M. TAMIMIR., J. BAERH., +8 authors C. COLLINSL.
    • Mod Pathol
    • 2008

    Phase II study of sunitinib, an oral multitargeted tyrosine kinase inhibitor, in patients with metastatic breast cancer previously treated with an anthracycline and a taxanes

    • H J.BURSTEIN, A D.ELIAS, +9 authors K D.MILLER
    • J Clin Oncol,
    • 2008
    VIEW 1 EXCERPT